Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Global knockout of VEGFB improves lipoprotein lipase activity leading to an improved lipid profile during diabetes.
Journal: Frontiers in pharmacology
Published: December 03, 2025
Impact of N-linked glycans on the dual short fibulin/LTBP-4 axes regulating elastogenesis.
Journal: The FEBS journal
Published: February 06, 2025
Heparanase Stimulation of Physiologic Cardiac Hypertrophy Is Suppressed After Chronic Diabetes, Resulting in Cardiac Remodeling and Dysfunction.
Journal: Diabetes
Published: March 15, 2024
Reduction in Insulin Uncovers a Novel Effect of VEGFB on Cardiac Substrate Utilization.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: December 27, 2023
Cardiac-specific VEGFB overexpression reduces lipoprotein lipase activity and improves insulin action in rat heart.
Journal: American journal of physiology. Endocrinology and metabolism
Published: November 08, 2021
Mutations in Fibronectin Cause a Subtype of Spondylometaphyseal Dysplasia with "Corner Fractures".
Journal: American journal of human genetics
Published: April 24, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026